Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 16/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.77 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5042973 | 0.90 | SLC6A9 (0.78) | SLC6A9KCNH2SLC6A5KDM4ESMN1; SMN2 | |
| SCHEMBL5047471 | 0.89 | SLC6A9 (0.77) | SLC6A9KCNH2SLC6A5KDM4ESMN1; SMN2 | |
| SCHEMBL5041981 | 0.88 | SLC6A9 (0.87) | SLC6A9KCNH2SLC6A5 | |
| SCHEMBL5041673 | 0.88 | SLC6A9 (0.73) | SLC6A9KCNH2SLC6A5 | |
| SCHEMBL4431409 | 0.88 | SLC6A9 (0.74) | SLC6A9KCNH2SLC6A5KDM4ESMN1; SMN2 | |
| SCHEMBL562797 | 0.87 | SLC6A9 (1.00) | SLC6A9KCNH2SLC6A5 | |
| SCHEMBL4432895 | 0.86 | SLC6A9 (0.75) | SLC6A9KCNH2SLC6A5KDM4ESMN1; SMN2 | |
| SCHEMBL4423743 | 0.86 | SLC6A9 (0.71) | SLC6A9KCNH2SLC6A5KDM4ESMN1; SMN2 | |
| SCHEMBL4425940 | 0.84 | SLC6A9 (0.78) | SLC6A9KCNH2 | |
| SCHEMBL5047582 | 0.82 | SLC6A9 (0.66) | SLC6A9KCNH2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656361-B1 | PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | disclosed |